Search results
The Emory Vaccine Center (EVC) is making fundamental advances in immunology, virology and vaccine research to search for life saving cures against the world's most threatening diseases plaguing millions of individuals around the globe.
Hope Clinic. The Hope Clinic of The Emory Vaccine Center serves as the clinical arm of the Emory Vaccine Center, directing all of our current on-site clinical vaccine trials, including those of the Merck & Co.-produced HIV vaccines, and provides translation of pre-clinical vaccine research into clinical trials in humans.
Our efforts are focused on developing both prophylactic vaccines (given to people ahead of infection) as well as therapeutic vaccines (given to HIV+ individuals). Similarly, the recent SARS-CoV-2 pandemic is responsible for more than 200 million cases worldwide with more than 4 million deaths.
7 cze 2022 · Emory University is participating in a Phase I clinical trial to evaluate the use of messenger RNA (mRNA) technology in HIV vaccines for the first time in humans. The trial, IAVI G002, was launched earlier this year by IAVI, a nonprofit scientific research organization.
21 lip 2022 · ATLANTA - Emory University is participating in a first-of-its-kind clinical trial for a possible HIV vaccine. Starting later this year, researchers at the Atlanta university will test the...
A future without infectious diseases starts with Hope. Clinical research saves lives, and you have the power to help! View our current Enrolling Studies. The Hope Clinic of Emory Vaccine Center is a center for excellence in clinical research for infectious disease prevention and treatment.
Emory Vaccine Center HIV/AIDS Research in the News: AIDS Vaccine 200 Mile Bike Ride Raises Hope for the Future of Vaccine Research. HIV Prevention Trials Ongoing. 15th Annual AIDS Vaccine Bike Ride. HIV Vaccine Design Should Adapt as Virus Mutates.
